GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cyfuse Biomedical KK (TSE:4892) » Definitions » ROE % Adjusted to Book Value

Cyfuse Biomedical KK (TSE:4892) ROE % Adjusted to Book Value : -14.68% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cyfuse Biomedical KK ROE % Adjusted to Book Value?

Cyfuse Biomedical KK's ROE % for the quarter that ended in Jun. 2024 was -30.09%. Cyfuse Biomedical KK's PB Ratio for the quarter that ended in Jun. 2024 was 2.05. Cyfuse Biomedical KK's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -14.68%.


Cyfuse Biomedical KK ROE % Adjusted to Book Value Historical Data

The historical data trend for Cyfuse Biomedical KK's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyfuse Biomedical KK ROE % Adjusted to Book Value Chart

Cyfuse Biomedical KK Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - -6.24 -8.99

Cyfuse Biomedical KK Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -8.12 -9.87 -3.61 -14.92 -14.68

Competitive Comparison of Cyfuse Biomedical KK's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Cyfuse Biomedical KK's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cyfuse Biomedical KK's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cyfuse Biomedical KK's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Cyfuse Biomedical KK's ROE % Adjusted to Book Value falls into.



Cyfuse Biomedical KK ROE % Adjusted to Book Value Calculation

Cyfuse Biomedical KK's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-16.90% / 1.88
=-8.99%

Cyfuse Biomedical KK's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-30.09% / 2.05
=-14.68%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cyfuse Biomedical KK ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Cyfuse Biomedical KK's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Cyfuse Biomedical KK Business Description

Traded in Other Exchanges
N/A
Address
3-5-27, Mita, West Wing-1st Floor. Sumitomo Fudosan Mita Twin Building, Minato-ku, Tokyo, JPN
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.

Cyfuse Biomedical KK Headlines

No Headlines